Accueil › Annuaire des chercheurs › Charles Sande
Charles Sande
Affiliation : Kenya Medical Research Institute · KEMRI-Wellcome Trust Research Programme
- 23Publications (affiliation kényane)
Profil de recherche
Charles Sande compte 23 publications référencées (2007–2026). Ses travaux paraissent principalement dans « PLoS ONE », « Nature Communications » et « The Lancet Infectious Diseases ». Son article le plus cité, « Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape » (2022), a été cité 423 fois. 6 de ces publications datent des trois dernières années d’activité. Ses travaux sont cosignés avec au moins 12 chercheurs, notamment dans des établissements de Royaume-Uni, Pays-Bas, Malawi, Bangladesh.
C’est vous ? Faites connaître vos travaux
Créez gratuitement votre profil DzCademia et ajoutez vos articles : ils apparaîtront plus facilement sur Google et dans les assistants d’IA comme ChatGPT. Plus de personnes pourront vous lire et vous citer.
Créer mon profil gratuit Ajouter mes publicationsPublications (23)
- Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns
- Bridging the implementation gap: Challenges and opportunities for integrating whole genome sequencing in tuberculosis surveillance in low-resource settings
- Genomic and clinical epidemiology of SARS-CoV-2 in coastal Kenya: insights into variant circulation, reinfection, and multiple lineage importations during a post-pandemic wave
- Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
- The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
- Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
- Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
- Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries
- Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013
- Priorities for developing respiratory syncytial virus vaccines in different target populations
- Airway response to respiratory syncytial virus has incidental antibacterial effects
- Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics
- Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
- Development of respiratory syncytial virus (RSV) vaccines for infants
- Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya
- Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya
- The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
- Kinetics of the Neutralizing Antibody Response to Respiratory Syncytial Virus Infections in a Birth Cohort
- The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease
- Genetic Relatedness of Infecting and Reinfecting Respiratory Syncytial Virus Strains Identified in a Birth Cohort From Rural Kenya
- Group- and Genotype-Specific Neutralizing Antibody Responses Against Respiratory Syncytial Virus in Infants and Young Children With Severe Pneumonia
- The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya
- Comparison of strain‐specific antibody responses during primary and secondary infections with respiratory syncytial virus
Revues de publication
- PLoS ONE × 3
- Nature Communications × 2
- The Lancet Infectious Diseases × 2
- Vaccine × 2
- Journal of Medical Virology × 2
- The Journal of Infectious Diseases × 2
Publications par année
- 20262
- 20252
- 20242
- 20222
- 20211
- 20201
- 20191
- 20181
- 20172
- 20161
Collaborations
Établissements partenaires : The Childhood Acute Illness and Nutrition Network · University of Warwick · University of Oxford · Pwani University · London School of Hygiene & Tropical Medicine
Pays des co-auteurs : Royaume-Uni · Pays-Bas · Malawi · Bangladesh
Co-auteurs
- D. James Nokes
- Martin N. Mutunga
- Patrick K. Munywoki
- Joyce Uchi Nyiro
- Charles N. Agoti
- James Nyagwange
- Rachel Ochola
- Emelda A. Okiro
- Patience Kerubo Kiyuka
- James M. Njunge
- Arnold W. Lambisia
- Lynette Isabella Ochola‐Oyier
Données bibliographiques issues d’OpenAlex (base ouverte).
Pourquoi choisir DzCademia ?
Pour donner à vos travaux plus de chances d’être découverts et recommandés par les IA. Profils, articles et communications : donnez à votre recherche une présence publique structurée. Les métadonnées intégrées aident les moteurs de recherche et les assistants IA à identifier vos travaux et à comprendre leurs références.
Commenter avec Google
Connecte-toi avec Google pour commenter directement sur cette page.